Evaxion to announce business update and full year 2024 financial results on April 1, 2025
Provided By GlobeNewswire
Last update: Mar 27, 2025
COPENHAGEN, Denmark, March 27, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its full year 2024 financial results on Tuesday April 1, 2025, before opening of the Nasdaq CM.
Read more at globenewswire.com
